{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:22:18Z","timestamp":1791487338208,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.euroneuro.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:08:46Z","timestamp":1669280926000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1194-0180","authenticated-orcid":false,"given":"Laila","family":"Tanana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-8540","authenticated-orcid":false,"given":"Prasad S.","family":"Nishtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy F.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0001","series-title":"2016: IRSAD. Australian Bureau of Statistics","article-title":"Census of Population and Housing: socio-Economic Indexes for Areas (SEIFA)","year":"2018"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0002","series-title":"Australian Statistical Geography Standard (ASGS) Edition 3. Australian Bureau of Statistics","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0003","series-title":"Rural & remote health. Australian Institute of Health and Welfare","year":"2020"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","article-title":"Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012","volume":"26","author":"Bachmann","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.euroneuro.2017.03.002","article-title":"Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012","volume":"27","author":"Bachmann","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/cap.2019.0032","article-title":"Psychotropic medication prescription rates and trends for new zealand children and adolescents 2008-2016","volume":"30","author":"Barczyk","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0007","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12888-017-1232-3","article-title":"Influence of socioeconomic status on antipsychotic prescriptions among youth in France","volume":"17","author":"Bonnot","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0008","series-title":"General Practice Activity in Australia 2015\u201316","author":"Britt","year":"2016"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0009","series-title":"Canadian ADHD Practice Guidelines","year":"2020"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0010","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/00048674.2011.610743","article-title":"Management of children's psychological problems in general practice 1970-1971, 1990-1991 and 2008-2009","volume":"45","author":"Charles","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0011","first-page":"10","article-title":"Prescribing pattern of antidepressants in children and adolescents: findings from the research on asia psychotropic prescription pattern","volume":"26","author":"Chee","year":"2016","journal-title":"East Asian Arch. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13033-020-00356-9","article-title":"Prevention and early intervention in youth mental health: is it time for a multidisciplinary and trans-diagnostic model for care?","volume":"14","author":"Colizzi","year":"2020","journal-title":"Int. J. Ment. Health Syst."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0013","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0006-3223(02)01372-0","article-title":"Development and natural history of mood disorders","volume":"52","author":"Costello","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0014","series-title":"The Social and Economic Costs of ADHD in Australia","year":"2019"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/YIC.0000000000000216","article-title":"Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study","volume":"33","author":"Deng","year":"2018","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0016","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","article-title":"Association of off-label drug use and adverse drug events in an adult population","volume":"176","author":"Eguale","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0017","series-title":"Product Information","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0018","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/0004867415615948","article-title":"Mental disorders and distress: associations with demographics, remoteness and socioeconomic deprivation of area of residence across Australia","volume":"50","author":"Enticott","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0019","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.3390\/ijerph18178906","article-title":"Migrants and Service Providers' Perspectives of Barriers to Accessing Mental Health Services in South Australia: a Case of African Migrants with a Refugee Background in South Australia","volume":"18","author":"Fauk","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1440-1614.2001.00902.x","article-title":"The Christchurch Health and Development Study: review of findings on child and adolescent mental health","volume":"35","author":"Fergusson","year":"2001","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0021","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1367493515620913","article-title":"ADHD medication prescription: effects of child, sibling, parent and general practice characteristics","volume":"20","author":"Heins","year":"2016","journal-title":"J. Child Health Care"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0022","first-page":"139","article-title":"Improving mental health access for low-income children and families in the primary care setting","author":"Hodgkinson","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0023","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1017\/S2045796020000293","article-title":"Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study","volume":"29","author":"Kaguelidou","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0024","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/0004867414538675","article-title":"Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009 to 2012: focus on children, adolescents and prescriber specialty","volume":"48","author":"Karanges","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0025","first-page":"1","article-title":"Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018","author":"Klau","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0026","series-title":"The Mental Health of Children and Adolescents: Report on the Second Australian Child and Adolescent Survey of Mental Health and Wellbeing","author":"Lawrence","year":"2015"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0027","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ajpy.12086","article-title":"Gender differences in adolescent depression: differential female susceptibility to stressors affecting family functioning","volume":"67","author":"Lewis","year":"2015","journal-title":"Aust. J. Psychol."},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0028","series-title":"Product Information","year":"2022"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0029","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/13651501.2011.640939","article-title":"Outpatient treatment of children and adolescents with antidepressants in Croatia","volume":"16","author":"Marsanic","year":"2012","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ps.53.12.1508","article-title":"Datapoints: use of multiple psychotropic drugs by medicaid-insured and privately insured children","volume":"53","author":"Martin","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0031","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14656566.2018.1445720","article-title":"Psychotropic medications for highly vulnerable children","volume":"19","author":"McLaren","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/ipm.2013.66","article-title":"Paediatric psychotropic prescribing practices in Ireland","volume":"31","author":"McNicholas","year":"2014","journal-title":"Ir. J. Psychol. Med."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/peds.2008-2598","article-title":"Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES","volume":"125","author":"Merikangas","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2009.11.1\/krmerikangas","article-title":"Epidemiology of mental disorders in children and adolescents","volume":"11","author":"Merikangas","year":"2009","journal-title":"Dial. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0035","series-title":"Attention Deficit Hyperactivity disorder: Diagnosis and Management","year":"2018"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0036","series-title":"Depression in Children and Young people: Identification and Management","year":"2019"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0037","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1017\/S2045796018000252","article-title":"Prevalence, incidence and persistence of ADHD drug use in Japan","volume":"28","author":"Okumura","year":"2019","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0038","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaac.2012.12.006","article-title":"Psychotropic medication treatment of adolescents: results from the National Comorbidity Survey-Adolescent Supplement","volume":"52","author":"Olfson","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0039","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00228-019-02711-3","article-title":"Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data","volume":"75","author":"Piovani","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0041","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","article-title":"Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom","volume":"121","author":"Rani","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0042","series-title":"Professional Practice Guideline 7: Guidance for Psychotropic Medication Use in Children and Adolescents","year":"2015"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0043","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jad.2012.01.012","article-title":"Belief in the harmfulness of antidepressants: associated factors and change over 16 years","volume":"138","author":"Reavley","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0044","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JCP.0000000000000891","article-title":"Trends and patterns of antidepressant use in French children and adolescents from 2009 to 2016: a population-based study in the French health insurance database","volume":"38","author":"Revet","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archpedi.158.8.760","article-title":"Prevalence of and risk factors for depressive symptoms among young adolescents","volume":"158","author":"Saluja","year":"2004","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0046","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/pds.4289","article-title":"Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011","volume":"26","author":"Schroder","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0047","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1089\/cap.2016.0202","article-title":"Extent and Risks of Antipsychotic Off-Label Use in Children and Adolescents in Germany Between 2004 and 2011","volume":"27","author":"Schroder","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0048","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11606-007-0345-7","article-title":"Access to mental health treatment by English language proficiency and race\/ethnicity","volume":"2","author":"Sentell","year":"2007","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0049","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2016045","article-title":"Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011","volume":"38","author":"Song","year":"2016","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/cap.2020.0154","article-title":"An international comparison of the information in the regulatory-approved drug labeling and prescribing guidelines for pediatric depression","volume":"31","author":"Tanana","year":"2021","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0051","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","first-page":"461","article-title":"Chapter 5: children and adolescents","author":"Taylor","year":"2018"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0052","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2018"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0053","series-title":"Product Information. Amdipharm Mercury (Australia) Pty Ltd","year":"2020"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00316","article-title":"New users of antipsychotics among children and adolescents in 2008-2017: a nationwide register study","volume":"11","author":"Varimo","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0055","series-title":"International Classification of Primary Care","year":"2003"},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0056","series-title":"World Health Organization Collaborating Centre For Drug Statistics Methodology","article-title":"Guidelines for ATC classification and DDD assignment","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0057","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mayocp.2012.04.017","article-title":"Ten common questions (and their answers) about off-label drug use","volume":"87","author":"Wittich","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.euroneuro.2022.09.007_bib0058","first-page":"1472","article-title":"Trends in psychotropic medication prescriptions in Urban China From 2013 to 2017: national population-based study","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.euroneuro.2022.09.007_sbref0059","series-title":"Product Information. Viatris Pty Ltd","year":"2021"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:05:36Z","timestamp":1760378736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22008677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":59,"alternative-id":["S0924977X22008677"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.09.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}